from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2635/-

LFCtreatmentdescriptionclass of inhibitor

-0.149

Amikacinug/mL Amikacintranslation

1.006

Cap5-10ug/mL Capreomycintranslation

0.755

Rox10-50 ug/mL Roxithromycintranslation

0.336

SM2-5 ug/mL Streptomycintranslation

-0.404

Tet5-10 ug/mL Tetracyclinetranslation

-0.069

Rif0.2-5ug/mL Rifampicintranscription

-0.230

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.214

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.029

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.092

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.306

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.181

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.429

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.304

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.911

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.018

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.811

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.200

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.216

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.969

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.259

KCN5-20 ug/mL Potassium cyaniderespiration

-0.888

NaN30.2-2 mM Sodium aziderespiration

-0.475

Nigericin50 uM Nigericinrespiration

1.222

TRC10-150 ug/mL Triclosanrespiration

0.128

TRZ10-25 ug/mL Thioridazinerespiration

0.450

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.194

menadione6-10 ug/mL Menadionerespiration

0.686

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

1.119

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-1.294

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.352

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.014

NRP_1Non-replicating persistence stage 1dosRassociated

-0.433

Amp0.2mg/mL AmpicillincellWall

0.038

Cephalexin20-100 ug/mL CephalexincellWall

0.990

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.408

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.011

EMB10-20 ug/mL EthambutolcellWall

-0.339

Eta12-40 ug/mL EthionamidecellWall

-0.685

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.207

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.917

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.397

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.619

BZA0.12 mg/mL BenzamidearomaticAmides

0.064

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.256

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.242

H2O24 mM hydrogen peroxideDNAdamaging

1.448

Levo10 ug/mL LevofloxacinDNAdamaging

-0.592

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.188

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.206

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.751

UVUV-irradiationDNAdamaging

1.070

ARP41-4 ug/mL Antitubercular compound ARP4?

0.631

Antimycin12.5-50 ug/mL Antimycin A?

0.305

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.840

PA_110-50 ug/mL Antitubercular compound PA-1?

0.677

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.291

PA8240.2-2 ug/mL PA-824?

1.279

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.460

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.002

Verapamil50 uM Verapamil?

0.023

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.389

methoxatin10-20 ug/mL Methoxatin?